DOSIsoft has announced the release of PLANET® Onco Dose version 3.2, a voxel-based dosimetry platform for radiation oncology, now approved for use in the EU and US. The software supports multiple radionuclides and offers optimized workflows for clinicians, enhancing patient comfort and streamlining clinical processes. This release allows for broader therapy coverage, including treatments involving various isotopes. CEO Marc Uszynski highlighted the achievement as a result of their commitment to safety and compliance, with plans for the software to benefit patients worldwide. DOSIsoft specializes in dosimetry solutions and has a global presence in healthcare facilities.
Mon, 07 Apr 2025 12:00:00 GMT | PR Newswire